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Colorectal cancer (CRC) is unfortunately an all-too 
common lethal disease and is a major health concern that 
affects men and women equally. Worldwide it accounts for 
approximately 1 million new cancers and one-half million 
deaths, equating 10 percent of all cancer deaths annually .
1
 
Colon cancer arises from mucosal co lonic polyps. Colon 
cancer commonly known as bowel cancer, is a cancer 
caused by uncontrolled cell growth (neoplasia), in the 
colon, rectum, or vermiform appendix. Colorectal cancers 
start in the lining of the bowel. It can grow into the muscle 
layers underneath and then through the bowel wall (If left  
untreated). 
Curcumin is the principal curcuminoid of the popular 
Indian spice turmeric, which is a member o f the ginger 
family (Zingiberaceae). The curcuminoids are polyphenols 
and are responsible for the yellow co lor of turmeric.
2  
 Curcumin is a potential anticancer drug it show its effect 
through Molecular Targets in Colon Cancer.
 
Accumulat ing 
evidence suggests that curcumin has a diverse range of 
molecular targets. This polyphenol modulates various 
targets through direct interaction or modulat ion of gene 
expression. Curcumin physically binds to as many as 33 
different proteins, including thioredoxin reductase, 
cyclooxygenase-2 (COX-2), protein kinase C (PKC), 5-
lipoxygenase (5-LOX), and tubulin. Molecular targets 
modulated by this agent are transcription factors, growth 
factors and their receptors, cytokines, enzymes, and genes 
that regulate cell pro liferat ion and apoptosis.
3 
Microspheres are one of the multipart iculate delivery  
systems and are prepared to obtain prolonged or controlled 
drug delivery, to improve bioavailab ility or stability and to 
target drug to specific sites. Microspheres can also offer 
advantages like limit ing fluctuation within therapeutic 
range, reducing side effects, decreasing dosing frequency 
and improving patient compliance.
 
2. MATERIALS AND METHODS:
 
Curcumin is a gift sample from Natural Remedies , 
Bangalore. Eudragit S 100, Propan-1-o l and Chloroform 
were also used in study. All the reagents and solvents used 
were of analytical grade satisfying pharmacopoeial 
standards. 
2.1 Preparation of micros pheres 
Curcumin microspheres were prepared by solvent 
evaporation technique
5
. Eudragit S 100 was dissolved in a 
mixture of Propan-1-ol and Chloroform (1:2) at room 
temperature. Curcumin was added to the above solution 
stirred in a magnetic stirrer to form a homogeneous 
solution. Then the above solution poured into 100ml of 
water containing 0.02% of Sodium laury l sulfate 
maintained at room temperature and stirred at 1000 rpm 
for 90 minutes, the resultant mixtures was filtered then 
wash with distilled water. The microspheres formed were 
then dried at room temperature. Three different 
formulat ions with different drug: polymer ratios (1:1, 1:2, 
1:3) were prepared. 
2.2. Encapsulation efficiency of the microspheres
6 
About 50mg of microspheres were weighed which was 
dissolved in Ethanol and made up to 100ml with distilled  
water shaken in mechanical shaker for 24h. Then solution 
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was filtered and made suitable dilution and analyzed 
spectrophotometrically at 427nm. 
2.3. Scanning electron microscope analysis 
Shapes and surface characteristics of the microspheres 
were investigated and photographed using scanning 
electron microscope (SEM; JEOL JSM T-330A, Japan). 
2.4 Particle size analysis 
Measurements of the particle size d istribution of 
microspheres were carried out with an optical microscope. 
Stage micrometer was used to calculate calibrat ion factor. 
The particle size was calculated by multiply ing the number 
of division of the ocular disc occupied by the particle with 
calibrat ion factor. Hundred randomly chosen spheres were 
taken to measure their indiv idual size.  
2.5 Differential Scanning Calorimetry 
The physical state of Curcumin in the microspheres was 
analyzed by Differential Scanning Calorimeter (Mettler-
Toledo star 822
e 
system, Switzerland). The thermo grams 
of the Curcumin, physical mixture of Curcumin and 
polymer, and Curcumin microspheres were obtained at a 
scanning rate of 10°C/min conducted over a temperature 
range of 170–250°C, respectively. 
2.6 Drug polymer interaction (FTIR) study    
  FTIR spectroscopy was performed on Fourier transform 
infrared spectrophotometer. The pellets of drug and 
potassium bromide were prepared by compressing the 
powders at 20 psi for 3 min on KBr-press and the spectra 
were scanned in the wave number range of 4000- 600 cm
-1
. 
FT-IR study was carried on Curcumin, physical mixture of 
Curcumin, and Curcumin microspheres. 
2.7 Coating of Hard Gelatin Capsules
7, 8 
Hard gelat in capsules of ‘size 0’ were chosen for coating. 
The bodies and caps separated manually. Curcumin  
microspheres equivalent to 5 mg of curcumin were 
accurately weighed and filled into the bodies by hand 
filling and the cap was replaced. The enteric coating 
solution was prepared by using the formula which is given 
in table1. The capsules were completely coated with 5% 
CAP by dip coating method. The capsules were 
alternatively dipped in 5% CAP solution and dried. 
Coating was repeated until an expected weight gain 8-12% 
was obtained and capsule resists disintegration in 0.1N 
HCl for minimum of 2 hrs. Percentage weight gain of the 
capsules before and after coating was determined.  








1 CAP 6 
2 Titanium dioxide 2.6 
3 Diethyl phthalate 2.2 
4 Acetone 59.4 
5 Isopropyl alcohol 30.8 
 
2.7 In vitro dissolution studies
9 
Dissolution studies were carried out by using USP type II 
dissolution test apparatus by rotating basket method in 
stimulated gastric fluid pH 1.2 for 2 h, pH6.8 for 3 h and 
pH 7.4 for next 5 h. The dissolution media were 
maintained at a temperature of 37 ± 5
0 
C. The speed of 
rotation of basket maintained was 100 rpm.  
Enteric coated capsules which were previously filled with 
Curcumin microspheres were placed in basket in  each 
dissolution vessel and covered with nylon cloth to prevent 
floating. 1 ml of dissolution media was withdrawn at 
predetermined time intervals and fresh dissolution media 
was replaced. The withdrawn samples were analyzed and 
the amount of Curcumin released was determined by UV 
absorption spectroscopy at 427 nm.   
3. RES ULTS AND DIS CUSSION: 
Microspheres of Curcumin were prepared by solvent 
evaporation techniques by using polymer   like Eudragit S 
100. The prepared Curcumin microspheres were then 
subjected to FT-IR, SEM, part icle size, size d istribution, % 
yield, drug content, entrapment efficiency, in vitro 
dissolution, release kinetics, and DSC. 
 First, trials were made to prepare microspheres by using a 
solvent evaporation technique in the chloroform/ liquid  
paraffin system was used but no spherical particles could 
be obtained. Then water phase is used and various 
formulat ions with different polymer and drug ratios were 
tried, stirring speed was also changed to obtain spherical 
particles. These microsphere formulations are shown in 
table 2. 
Loading efficiency of the drug depended on solubility of 
drug in solvents and continuous phase and physic chemical 
properties of drug and polymer
10
. High encapsulation 
efficiency was observed in different formulat ion of 
Curcumin Encapsulation efficiency is given in table: 3.   
The mean particle size of Curcumin microspheres was in 
range of 29.21-31.27µm. As it was evident from the results 
that particle size increases as polymer concentration was 
increased. The data showing particle size analysis is given 
in table: 4. 
Table: 2 Formulation details of Eudragit S  100 microspheres 
of Curcumin 
Ingredients Formulation codes 
A-1  A-2  A-3  
Curcumin (mg) 50 50 50 
Eudragit S 100(mg) 50 100 150 
Propan-1-o l and 
Chloroform (1:2) in ml 
12 12 12 
Sodium lauryl sulfate  0.02 % 0.02 % 0.02 % 
Water (ml) 100 100 100 
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Drug content (%) 
Entrapment 
Efficiency (%) 
A1 57.5  15.81  21.73  
A2 45.33  18.6 36.73  
A3 56.25  14.83 43.75  
 
Table: 4 Particle size analysis of Curcumin 
micros pheres 
Formulat ion Average size  (μm) 
A1 29.21 7.91 
A2 30.41 11.4 
A3 31.27 5.56 
 
From Scanning electron microscopy, it was observed that 
particles were spherical. The surface of the drug-loaded 
Eudragit S 100 microspheres shown in Figure: 1. Eudragit  
S 100 microspheres showed smooth surface. All the 
microspheres had small pores on their surfaces, which will 
be responsible for release. 
 
Figure: 1 S EM images of Eudragit L 100micros pheres 
of Curcumin 
 
Drug polymer interaction can be studied by FT-IR 
analysis. Figure: 2 show the IR spectra of pure Curcumin, 
drug loaded microspheres and physical mixture. The same 
peaks were also reported in all drug loaded microspheres 
and in physical mixture. There was no change or shifting 
of characteristic peaks in drug loaded microspheres 
suggested that there was no significant drug polymer 
interaction which  indicates the stable nature of drug in all 
formulat ions. 
Any possible drug polymer interaction can also be studied 
by thermal analysis. DSC studies were performed  on pure 
drug and drug-loaded microspheres. DSC themograms of 
pure Curcumin (figure: 3) showed a sharp endothermic 
peak at 176.77°C.  The themograms of formulation also 
showed a similar endothermic peak at 180.24°C. This 
further confirms that there is no drug polymer interaction.  
 
Figure: 2 FT IR s petra of pure Curcumin(A) physical 
mixture(B) Eudragit S 100microspheres(C)
 
Figure: 3 DSC thermograms of Curcumin (A) Curcumin micros pheres (B)  
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Drug release from microspheres was sustained up to 10 
hours. Different formulation showed different degree of 
release (figure: 4). the cumulative release of Curcumin  
significantly decreased with increasing Eudragit S 
100concentration. The increased density of the polymer 
matrix at h igher concentrations results in an increased 
diffusion path length
11
. After 10 hours drug release from 
different formulation was in range of 66.12 to 71.87 %. 
                     
 
Figure: 4 Cumulative percentage drug release profile of 
Curcumin micros pheres (A1, A2 &A3) 
The in-vitro release data was fitted to various kinetic 
models in order to find out the drug release mechanis m. 
The ‘n’ value obtained from Korsemeyer- Peppas equation 
for Eudragit L 100was in range of 0.365 to 0.371 
suggested that the drug release from microspheres 
followed fickian d iffusion mechanism
12
. 
4. CONCLUS ION: 
The Curcumin loaded microspheres were prepared by 
solvent evaporation method using Eudragit S 100. 
Polymer: drug ratio and stirring speed of the system were 
important to obtain spherical particles with smooth 
surfaces. The yields of preparation and encapsulation 
efficiencies were very high for all microspheres obtained. 
The prepared microspheres were free flowing and discrete. 
The FT-IR and DSC suggested no drug polymer 
interaction during encapsulation process. The drug release 
was studied up to 10 hours and results indicate that release 
of drug from microspheres followed fickian diffusion 
mechanis m. 
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